Skip to content

Insider · CIK 0001661780

TAYTON-MARTIN HELEN KATRINA

Reports to the SEC for 3 companies · HORSHOLM

Transactions

23

Companies

3

Filings

11

CIK

0001661780

Forms 4 and 5

Insider transactions

23 trades
DateCompanyValue
2024-01-15ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award—
2024-01-15ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award—
2023-01-17ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award—
2023-01-17ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award—
2023-01-17ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award—
2022-01-12ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award—
2022-01-12ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award—
2021-11-17Trillium Therapeutics Inc.Deferred Share UnitD Disposition to Issuer—
2021-11-17Trillium Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer—
2021-03-03ADAPAdaptimmune Therapeutics PLCM Exercise/Conversion+$280K
2021-01-11ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award—
2021-01-11ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award—
2020-08-03ADAPAdaptimmune Therapeutics PLCS Sale−$1.75M
2020-01-16ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award—
2020-01-16ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award—
2020-01-13ADAPAdaptimmune Therapeutics PLCS Sale−$200K
2020-01-13ADAPAdaptimmune Therapeutics PLCS Sale−$250K
2019-01-04ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award—
2019-01-04ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award—
2018-01-12ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award—
2018-01-12ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award—
2017-01-13ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award—
2016-01-18ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award—